Bicycle Therapeutics is a biopharmaceutical company that focuses on creating groundbreaking therapeutic treatments using its proprietary bicycle technology platform

This innovative platform generates a new class of medicines known as bicyclic peptides, which are designed to deliver targeted therapies for various diseases, including cancer and other serious conditions. The company’s research and development efforts aim to enhance the efficacy and safety of treatments by leveraging the unique properties of these cyclic peptide compounds, thus addressing unmet medical needs in the pharmaceutical landscape. Through collaboration with industry partners and ongoing clinical trials, Bicycle Therapeutics strives to advance its pipeline of potential drug candidates toward commercialization.